Literature DB >> 20605817

International classification of disease coding for obstructive lung disease: does it reflect appropriate clinical documentation?

Philip Marcus1, Sidney S Braman.   

Abstract

International Classification of Disease coding is widely used by physicians, hospitals, health-care payers, and governments to assess the health of populations and as a means of reimbursement for medical care based on diagnosis and severity of illness. The current classification system, International Classification of Diseases, 9th ed (ICD-9), will soon be replaced by International Classification of Diseases, 10th ed (ICD-10). When the codes that relate to COPD and asthma are examined, the clinical relevance of the categories in International Classification of Disease coding must be questioned. In the future, a more simplified terminology that is consistent with clinical usage could improve accuracy and ease of coding. At present, however, clinicians should become familiar with the present ICD-9 and future ICD-10 codes so that their descriptions of illnesses in the medical records more accurately reflect current coding terminology.

Entities:  

Mesh:

Year:  2010        PMID: 20605817     DOI: 10.1378/chest.09-1342

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.

Authors:  Brian D Stein; Adriana Bautista; Glen T Schumock; Todd A Lee; Jeffery T Charbeneau; Diane S Lauderdale; Edward T Naureckas; David O Meltzer; Jerry A Krishnan
Journal:  Chest       Date:  2011-07-14       Impact factor: 9.410

2.  Sex and racial/ethnic differences in the reason for 30-day readmission after COPD hospitalization.

Authors:  Tadahiro Goto; Mohammad Kamal Faridi; Koichiro Gibo; Carlos A Camargo; Kohei Hasegawa
Journal:  Respir Med       Date:  2017-07-25       Impact factor: 3.415

3.  Use of administrative claims data for identifying patients with cirrhosis.

Authors:  Mahendra S Nehra; Ying Ma; Christopher Clark; Ruben Amarasingham; Don C Rockey; Amit G Singal
Journal:  J Clin Gastroenterol       Date:  2013 May-Jun       Impact factor: 3.062

4.  What are the factors influencing outcome among patients admitted to a hospital with a proximal humeral fracture?

Authors:  Valentin Neuhaus; Christiaan H J Swellengrebel; Jeroen K J Bossen; David Ring
Journal:  Clin Orthop Relat Res       Date:  2013-03-01       Impact factor: 4.176

5.  Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.

Authors:  Degan Lu; Yanru Qiao; Karen C Johnson; Junling Wang
Journal:  J Asthma       Date:  2016-09-27       Impact factor: 2.515

6.  Treatment choice affects inpatient adverse events and mortality in older aged inpatients with an isolated fracture of the proximal humerus.

Authors:  Valentin Neuhaus; Arjan G J Bot; Christiaan H J Swellengrebel; Nitin B Jain; Jon J P Warner; David C Ring
Journal:  J Shoulder Elbow Surg       Date:  2013-10-14       Impact factor: 3.019

7.  Racial and Ethnic Disparities in Influenza Vaccination among Adults with Chronic Medical Conditions Vary by Age in the United States.

Authors:  Degan Lu; Yanru Qiao; Natalie E Brown; Junling Wang
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.